Mangia A - Search Results

1

Development of a multigenic plasmid vector for HCV DNA immunization.

Papa S, Rinaldi M, Mangia A, Parrella P, Signori E, Lombardi L, Fazio VM. Papa S, et al. Among authors: mangia a. Res Virol. 1998 Sep-Oct;149(5):315-9. doi: 10.1016/s0923-2516(99)89012-8. Res Virol. 1998. PMID: 9879611

2

Lack of hepatitis C virus replication intermediate RNA in diseased skin tissue of chronic hepatitis C patients.

Mangia A, Andriulli A, Zenarola P, Lomuto M, Cascavilla I, Quadri R, Negro F. Mangia A, et al. J Med Virol. 1999 Nov;59(3):277-80. doi: 10.1002/(sici)1096-9071(199911)59:3<277::aid-jmv3>3.0.co;2-e. J Med Virol. 1999. PMID: 10502256

3

High RAD51 mRNA expression characterize estrogen receptor-positive/progesteron receptor-negative breast cancer and is associated with patient's outcome.

Barbano R, Copetti M, Perrone G, Pazienza V, Muscarella LA, Balsamo T, Storlazzi CT, Ripoli M, Rinaldi M, Valori VM, Latiano TP, Maiello E, Stanziale P, Carella M, Mangia A, Pellegrini F, Bisceglia M, Muda AO, Altomare V, Murgo R, Fazio VM, Parrella P. Barbano R, et al. Among authors: mangia a. Int J Cancer. 2011 Aug 1;129(3):536-45. doi: 10.1002/ijc.25736. Epub 2010 Dec 9. Int J Cancer. 2011. PMID: 21064098

4

[Towards new quantitative tests].

Mangia A. Mangia A. Minerva Gastroenterol Dietol. 1995 Mar;41(1):11-5. Minerva Gastroenterol Dietol. 1995. PMID: 7619956 Italian. No abstract available.

5

HCV genotypes in patients with liver disease of different stages and severity.

Mangia A, Cascavilla I, Lezzi G, Spirito F, Maertens G, Parlatore L, Saracco G, Rizzetto M, Andriulli A. Mangia A, et al. J Hepatol. 1997 Jun;26(6):1173-8. doi: 10.1016/s0168-8278(97)80449-7. J Hepatol. 1997. PMID: 9210601

6

High doses of interferon in combination with ribavirin are more effective than the standard regimen in patients with HCV genotype 1 chronic hepatitis.

Mangia A, Santoro R, Piattelli M, Leandro G, Minerva N, Annese M, Bacca D, Spirito F, Carretta V, Ventrella F, Cela M, Andriulli A. Mangia A, et al. J Hepatol. 2002 Jul;37(1):109-16. doi: 10.1016/s0168-8278(02)00140-x. J Hepatol. 2002. PMID: 12076869 Clinical Trial.

7

IL-10 haplotypes as possible predictors of spontaneous clearance of HCV infection.

Mangia A, Santoro R, Piattelli M, Pazienza V, Grifa G, Iacobellis A, Andriulli A. Mangia A, et al. Cytokine. 2004 Feb 7;25(3):103-9. doi: 10.1016/j.cyto.2003.10.005. Cytokine. 2004. PMID: 14698136

8

Treatment of patients with HCV infection with or without liver biopsy.

Andriulli A, Persico M, Iacobellis A, Maio G, Di Salvo D, Spadaccini A, Bacca D, Leandro G, Ventrella F, Mangia A. Andriulli A, et al. Among authors: mangia a. J Viral Hepat. 2004 Nov;11(6):536-42. doi: 10.1111/j.1365-2893.2004.00519.x. J Viral Hepat. 2004. PMID: 15500554 Clinical Trial.

9

Short-term treatment duration for HCV-2 and HCV-3 infected patients.

Andriulli A, Dalgard O, Bjøro K, Mangia A. Andriulli A, et al. Among authors: mangia a. Dig Liver Dis. 2006 Oct;38(10):741-8. doi: 10.1016/j.dld.2006.06.006. Epub 2006 Aug 17. Dig Liver Dis. 2006. PMID: 16916631

10

Meta-analysis: the outcome of anti-viral therapy in HCV genotype 2 and genotype 3 infected patients with chronic hepatitis.

Andriulli A, Mangia A, Iacobellis A, Ippolito A, Leandro G, Zeuzem S. Andriulli A, et al. Among authors: mangia a. Aliment Pharmacol Ther. 2008 Aug 15;28(4):397-404. doi: 10.1111/j.1365-2036.2008.03763.x. Epub 2008 Jun 11. Aliment Pharmacol Ther. 2008. PMID: 18549461 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

431 results

Search Page

Filters